Your Article Summary
See Latest ArticlesSerious adverse events rarely reported after trivalent inactivated influenza vaccine (TIV) in children 6–23 months of age
Vaccine , 06/26/09
Rosenberg M et al. - Although the number of SAE increased over time, the most common types of events remained unchanged with no new or unexpected safety concerns identified with expanded TIV use.
Today in Peds Allergy/Immunology...keeping you current
Receive free subspecialty "5-minute updates" via email
Role of adenoids and adenoiditis in children with allergy and otitis media
Current Allergy and Asthma Reports, 10/22/09
Montelukast in the treatment of asthma and beyond
Expert Review of Clinical Immunology, 11/23/09
Update on vaccination guidelines for allergic children
Expert Review of Vaccines, 10/29/09
Today in Vaccine/Immunotherapy...keeping you current
Receive free subspecialty "5-minute updates" via email
Update on vaccination guidelines for allergic children
Expert Review of Vaccines, 10/29/09
Safety of vaccination of patients with systemic lupus erythematosus
Lupus, 11/04/09
Yearly influenza vaccinations: a double-edged sword
The Lancet Infectious Diseases, 11/19/09